Home » INYX'S ASHTON PHARMACEUTICALS LAUNCHES PRODUCTION ON ASTHMA DRY POWDER INHALER
INYX'S ASHTON PHARMACEUTICALS LAUNCHES PRODUCTION ON ASTHMA DRY POWDER INHALER
Ashton Pharmaceuticals, Inc., a wholly owned subsidiary of Inyx, Inc., announced today that it has commenced production and initial deliveries for Merck Generics, on a formoterol Clickhaler, a dry powder inhaler developed by Innovata PLC and licensed by Merck for commercial marketing in Europe by its Respiratory business. Merck Generics is a wholly owned subsidiary of Merck KGaA of Darmstadt, Germany.
Yahoo News (http://biz.yahoo.com/prnews/051114/nem040.html?.v=21)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May